Literature DB >> 10412800

Colonic enteric nervous system in patients with familial amyloidotic neuropathy.

I Anan1, M El-Salhy, Y Ando, S Forsgren, N Nyhlin, H Terazaki, N Sakashita, O B Suhr.   

Abstract

The colonic enteric nervous system was investigated in autopsy specimens from 12 patients with familial amyloidotic neuropathy (FAP) and 9 controls. The infiltration of amyloid deposits in the enteric nervous system was studied by double staining for amyloid and nerve elements. The myenteric plexus was immunostained for protein gene product (PGP) 9.5, vasoactive intestinal peptide (VIP), substance P and nitric oxide synthase (NOS). The immunostained nerve elements were quantified by computerised image analysis. Double staining revealed that there was no amyloid infiltration in the ganglia, or in the nerve fibres in the colonic enteric nervous system of FAP patients. The relative volume density of PGP 9.5-immunoreactive nerve fibres in both the circular and the longitudinal muscle layers in FAP patients did not differ significantly from that of controls. The relative volume density of VIP-immunoreactive nerve fibres in the circular muscle layer was significantly decreased in FAP patients compared with controls, but not in the longitudinal layer. The number of VIP-immunoreactive neurons/mm2 myenteric ganglia was significantly decreased in FAP patients. There were no statistical differences in the relative volume density for substance P- and NOS-immunoreactive nerve fibres between FAP patients and controls, nor was there any difference between FAP patients and controls regarding the number of NOS- and substance P-immunoreactive neurons/mm2 myenteric ganglia. It is concluded that the colonic enteric nervous system as a whole is intact and is not damaged by amyloid infiltration. The present observation of a reduction of VIP-immunoreactive nerve fibres and neurons in myenteric plexus of FAP patients might be one of the factors that contribute to the motility disorders seen in FAP patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10412800     DOI: 10.1007/s004010051050

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

1.  Reduced distribution of pacemaking cells in dilated colon.

Authors:  Jonathan Sutcliffe; Sebastian K King; Melanie C Clarke; Pamela Farmer; John M Hutson; Bridget R Southwell
Journal:  Pediatr Surg Int       Date:  2007-12       Impact factor: 1.827

2.  Gastric emptying in hereditary transthyretin amyloidosis: the impact of autonomic neuropathy.

Authors:  J Wixner; P Karling; A Rydh; R Hörnsten; U Wiklund; I Anan; O B Suhr
Journal:  Neurogastroenterol Motil       Date:  2012-08-16       Impact factor: 3.598

3.  Glial cells in familial amyloidotic polyneuropathy.

Authors:  Nádia P Gonçalves; Susete Costelha; Maria J Saraiva
Journal:  Acta Neuropathol Commun       Date:  2014-12-18       Impact factor: 7.801

4.  Age-associated changes of the intrinsic nervous system in relation with interstitial cells in the pre-weaning goat rumen.

Authors:  Yu Liang; Imran Tarique; Waseem Ail Vistro; Yifei Liu; Ziyu Wang; Abdul Haseeb; Noor Samad Gandahi; Adeela Iqbal; Siyi Wang; Tianci An; Huan Yang; Qiusheng Chen; Ping Yang
Journal:  Aging (Albany NY)       Date:  2019-07-14       Impact factor: 5.682

Review 5.  Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis.

Authors:  Laura Obici; Ole B Suhr
Journal:  Clin Auton Res       Date:  2019-08-26       Impact factor: 4.435

6.  Loss of gastric interstitial cells of Cajal in patients with hereditary transthyretin amyloidosis.

Authors:  Jonas Wixner; Konen Obayashi; Yukio Ando; Pontus Karling; Intissar Anan
Journal:  Amyloid       Date:  2013-05-03       Impact factor: 7.141

7.  Small intestinal amyloidosis: a rare cause of diverticular disease.

Authors:  Gabriel M Groisman; Hector I Cohen
Journal:  Case Rep Pathol       Date:  2014-06-05

8.  Somatostatin analogues for refractory diarrhoea in familial amyloid polyneuropathy.

Authors:  Michael Collins; Anna Pellat; Guillemette Antoni; Hélène Agostini; Céline Labeyrie; David Adams; Franck Carbonnel
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.